Company Overview - Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on oncology, developing proprietary antibody-based therapeutics to treat various human diseases [3] - The company's scientific focus is on the interplay between angiogenesis, the immune system, and tumor growth, with a pipeline targeting critical biological pathways for effective anti-tumor responses [3] - Founded in 2014 and headquartered in Boston, Massachusetts, Compass Therapeutics aims to advance its product candidates through clinical development as standalone therapies and in combination with other proprietary antibodies [3] Upcoming Investor Events - Compass Therapeutics will participate in the Citizens Life Sciences Conference on May 8, 2025, at 1:30 PM ET in New York, NY [2] - The company will also attend the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ on May 20, 2025, at 11:30 AM ET, also in New York, NY [2] - Presentations from these events will be archived for 90 days on Compass's Events page [2]